139 related articles for article (PubMed ID: 28652780)
41. [Current events in immunotherapy for upper aerodigestive tract cancer].
Outh-Gauer S; Le Tourneau C; Broudin C; Scotte F; Roussel H; Hans S; Mandavit M; Tartour E; Badoual C
Ann Pathol; 2017 Feb; 37(1):79-89. PubMed ID: 28111039
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic utility of PLAG1 immunohistochemical determination in salivary gland tumors.
Rotellini M; Palomba A; Baroni G; Franchi A
Appl Immunohistochem Mol Morphol; 2014; 22(5):390-4. PubMed ID: 23958548
[TBL] [Abstract][Full Text] [Related]
43. Programmed death-1 ligands 1 and 2 expression in cutaneous squamous cell carcinoma and their relationship with tumour- infiltrating dendritic cells.
Jiao Q; Liu C; Li W; Li W; Fang F; Qian Q; Zhang X
Clin Exp Immunol; 2017 Jun; 188(3):420-429. PubMed ID: 28052400
[TBL] [Abstract][Full Text] [Related]
44. Expression of PD-1/PD-L1 and PD-L2 in peripheral T-cells from non-small cell lung cancer patients.
Arrieta O; Montes-Servín E; Hernandez-Martinez JM; Cardona AF; Casas-Ruiz E; Crispín JC; Motola D; Flores-Estrada D; Barrera L
Oncotarget; 2017 Nov; 8(60):101994-102005. PubMed ID: 29254220
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma.
Jung HI; Jeong D; Ji S; Ahn TS; Bae SH; Chin S; Chung JC; Kim HC; Lee MS; Baek MJ
Cancer Res Treat; 2017 Jan; 49(1):246-254. PubMed ID: 27456947
[TBL] [Abstract][Full Text] [Related]
46. Implications of methylation patterns of cancer genes in salivary gland tumors.
Williams MD; Chakravarti N; Kies MS; Maruya S; Myers JN; Haviland JC; Weber RS; Lotan R; El-Naggar AK
Clin Cancer Res; 2006 Dec; 12(24):7353-8. PubMed ID: 17189407
[TBL] [Abstract][Full Text] [Related]
47. Clinical implication of CD166 expression in salivary gland tumor.
Andisheh-Tadbir A; Ashraf MJ; Khademi B; Ahmadi S
Tumour Biol; 2015 Apr; 36(4):2793-9. PubMed ID: 25472586
[TBL] [Abstract][Full Text] [Related]
48. Twist Expression in Pleomorphic Adenoma, Adenoid Cystic Carcinoma and Mucoepidermoid Carcinoma of Salivary Glands.
Pardis S; Zare R; Jaafari-Ashkavandi Z; Ashraf MJ; Khademi B
Turk Patoloji Derg; 2016; 32(1):15-21. PubMed ID: 26832177
[TBL] [Abstract][Full Text] [Related]
49. PD-L1 expression of the residual tumor serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy.
Chen S; Wang RX; Liu Y; Yang WT; Shao ZM
Int J Cancer; 2017 Mar; 140(6):1384-1395. PubMed ID: 27925176
[TBL] [Abstract][Full Text] [Related]
50. [Malignant salivary gland tumors. Effect of histology and site on prognosis].
Chilla R; Casjens R; Eysholdt U; Droese M
HNO; 1983 Aug; 31(8):286-90. PubMed ID: 6629867
[TBL] [Abstract][Full Text] [Related]
51. PD-L1 and PD-L2 Are Differentially Expressed by Macrophages or Tumor Cells in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
Menguy S; Prochazkova-Carlotti M; Beylot-Barry M; Saltel F; Vergier B; Merlio JP; Pham-Ledard A
Am J Surg Pathol; 2018 Mar; 42(3):326-334. PubMed ID: 29112015
[TBL] [Abstract][Full Text] [Related]
52. Detailed Characterization of Immune Cell Infiltrate and Expression of Immune Checkpoint Molecules PD-L1/CTLA-4 and MMR Proteins in Testicular Germ Cell Tumors Disclose Novel Disease Biomarkers.
Lobo J; Rodrigues Â; Guimarães R; Cantante M; Lopes P; Maurício J; Oliveira J; Jerónimo C; Henrique R
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31614500
[No Abstract] [Full Text] [Related]
53. Immunohistochemichal Assessment of the CrkII Proto-oncogene Expression in Common Malignant Salivary Gland Tumors and Pleomorphic Adenoma.
Askari M; Darabi M; Jahanzad E; Mostakhdemian Hosseini Z; Musavi Chavoshi M; Darabi M
J Dent Res Dent Clin Dent Prospects; 2015; 9(1):29-34. PubMed ID: 25973151
[TBL] [Abstract][Full Text] [Related]
54. PD-L1 expression in small cell neuroendocrine carcinomas.
Schultheis AM; Scheel AH; Ozretić L; George J; Thomas RK; Hagemann T; Zander T; Wolf J; Buettner R
Eur J Cancer; 2015 Feb; 51(3):421-6. PubMed ID: 25582496
[TBL] [Abstract][Full Text] [Related]
55. Human kallikrein 6 expression in salivary gland tumors.
Darling MR; Jackson-Boeters L; Daley TD; Diamandis EP
J Histochem Cytochem; 2006 Mar; 54(3):337-42. PubMed ID: 16286664
[TBL] [Abstract][Full Text] [Related]
56. Expression of PD-L1 on Immune Cells Shows Better Prognosis in Laryngeal, Oropharygeal, and Hypopharyngeal Cancer.
Birtalan E; Danos K; Gurbi B; Brauswetter D; Halasz J; Kalocsane Piurko V; Acs B; Antal B; Mihalyi R; Pato A; Fent Z; Polony G; Timar J; Tamas L
Appl Immunohistochem Mol Morphol; 2018 Aug; 26(7):e79-e85. PubMed ID: 29271789
[TBL] [Abstract][Full Text] [Related]
57. Prognostic value of tumor PD-L1 expression combined with CD8
Wang Q; Lou W; Di W; Wu X
Int Immunopharmacol; 2017 Nov; 52():7-14. PubMed ID: 28846888
[TBL] [Abstract][Full Text] [Related]
58. Impact of PD-L1, transforming growth factor-β expression and tumor-infiltrating CD8
Duan J; Liu X; Chen H; Sun Y; Liu Y; Bai H; Wang J
Thorac Cancer; 2018 Nov; 9(11):1341-1353. PubMed ID: 30168897
[TBL] [Abstract][Full Text] [Related]
59. Prognostic Impact of Programmed Death-Ligand 2 Expression in Primary Lung Adenocarcinoma Patients.
Takamori S; Takada K; Azuma K; Jogo T; Shimokawa M; Toyokawa G; Hirai F; Tagawa T; Kawahara A; Akiba J; Okamoto I; Nakanishi Y; Oda Y; Hoshino T; Maehara Y
Ann Surg Oncol; 2019 Jun; 26(6):1916-1924. PubMed ID: 30815801
[TBL] [Abstract][Full Text] [Related]
60. Prognostic significance of PD-L1 expression and CD8+ T cell infiltration in pulmonary neuroendocrine tumors.
Wang H; Li Z; Dong B; Sun W; Yang X; Liu R; Zhou L; Huang X; Jia L; Lin D
Diagn Pathol; 2018 May; 13(1):30. PubMed ID: 29789013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]